OGI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now: price is breaking below near-term support (trading around 1.48 vs S1 1.494) with bearish momentum (MACD histogram negative and expanding).", "Upside case exists (bullish analyst stance + strong YoY revenue growth), but the chart is currently pointing lower and there\u2019s no proprietary buy signal to override that.", "Best \u201cimpatient\u201d setup would be to buy only after strength returns (reclaiming ~1.57 pivot and holding above it); until then, it\u2019s an avoid/hold."]
["Trend/Momentum: MACD histogram at -0.00848 and negatively expanding => downside momentum is strengthening.", "RSI(6) ~32.5: nearing oversold territory, which can support a short-term bounce, but it\u2019s not a confirmed reversal signal by itself.", "Moving averages: converging => indecision/transition phase, but current price action is weak (down ~5% on the day).", "Key levels: Support at S2 1.447 then 1.40 area; resistance at Pivot 1.571, then R1 1.647. A move back above 1.571 would materially improve the long entry quality."]
["Upcoming earnings: QDEC 2025 earnings on 2026-02-10 pre-market could spark a sharp move if margins/guide surprise positively.", "Analyst tone is constructive: recent initiations/target raises with Buy ratings and emphasis on category share gains and strategic relationship with BAT.", "Pattern-based forward look is mildly positive over 1 week to 1 month (+0.48% / +1.73% expected), implying downside may be slowing after the drop."]
["Near-term price action is risk-off: stock down sharply while the broader market is also weak (S&P 500 -1.25%), adding pressure to small-cap/high-beta names.", "No Intellectia proprietary buy signal today (neither AI Stock Picker nor SwingMax), so there\u2019s no \u201cmust-buy now\u201d trigger.", "Profitability quality concern: gross margin collapsed in the latest quarter snapshot, which can keep sellers active despite revenue growth."]
["Latest quarter: 2025/Q4.", "Revenue: 80.061M, up 79.12% YoY (strong top-line acceleration).", "Earnings/Losses: Net income -37.964M and EPS -0.28 (still loss-making).", "Margins: Gross margin 3.25, down 102.19% YoY (major deterioration; key issue to monitor going into the next print)."]
["Recent changes: Two Buy-rated updates in the last ~2 months\u2014Alliance Global raised PT to C$4 from C$3.60 (2025-12-16) and Canaccord initiated Buy with C$3 PT (2026-01-27).", "Wall Street pros view (bull case): Leading share in several product categories, expanding domestic/international sales momentum, and strategic BAT relationship.", "Wall Street cons view (bear case): Regulatory headwinds and structural inefficiencies in Canadian cannabis; profitability/margin execution remains the swing factor."]
